Benefit seen in patients with a history of vagus nerve stimulation or previous epilepsy surgery.

The patients in the study had an average age of 22 have epilepsy and 54 % of the 110 implanted patients had previously undergone resective surgery and / or vagus nerve stimulation therapy. Benefit seen in patients with a history of vagus nerve stimulation or previous epilepsy surgery. The study is ongoing in some patients after receiving DBS therapy for more than four years.

The portfolio in the field of grass allergy The results of recent clinical trial Circassia that four doses of ToleroMune T-cell vaccine greatly improved the allergic reactions in the trial measured -. The endpoints included the early phase skin response to a challenge dose of ragweed allergen During the study, both before and after the ragweed season. In contrast, conversely, the optimal ToleroMune T – cell vaccine regimen this seasonal increase and reduced it by a further 47 percent over the prior – ragweed season baseline. During the study, the ToleroMune vaccines were safe and well tolerated, associated with a safety profile similar to placebo treatment. Validate these very encouraging clinical results further our unique T-cell vaccine approach to allergy Our Our ToleroMune technology has the potential to both ragweed and cat shows treat allergies, and we hope to expand this range, when we get the.According to cat current studies using combination laser microscopy and the plasticity of cell tagging regions of the brain areas of the brain, especially central sites the learning, to the hippocampus.

– That brain contains two challenges of importance to maintain which functionality to a changing environment, said cat. One is to remain stable enough so to the basic things we must do consistency consistent interpreting the world. The second is, to continuously changing landscape that uses a high premium on the ability to neuronal circuits of adapt to adapt. .. Variety of compounds that neuron curtail twigs only to itself new.

The investigation has been the November 2003 issue of journal Nature Neuroscience of Howard Hughes Medical Institute in Lawrence Katz, and colleague Adi Mizrahi, well reports at Duke University Medical Centre.